Is allostatic load the measure of illness stage and neuroprogression in psychosis?

Błażej Misiak,Jerzy Samochowiec,Patryk Piotrowski
DOI: https://doi.org/10.1016/j.psyneuen.2023.106784
IF: 4.693
2024-02-01
Psychoneuroendocrinology
Abstract:Background It has been found that individuals with psychosis show a number of biological alterations in the peripheral blood that can be operationalized in frame of the allostatic load (AL) concept. Little is known about the AL at various stages of psychosis. Therefore, we aimed to compare the AL index in individuals at familial high risk of psychosis (FHR-P), those with first-episode psychosis (FEP), acutely relapsed individuals with schizophrenia (SCZ-AR) and healthy controls (HCs), taking into account clinical manifestation. Methods A total of 37 FHR-P individuals, 42 patients with FEP, 25 patients with SCZ-AR and 42 HCs were enrolled. The AL index was measured based on 15 biomarkers. Results The AL index was significantly increased in subjects with psychosis and FHR-P individuals compared to HCs. No significant differences between FHR-P individuals and those with FEP were found in terms of the AL index. The AL index was significantly higher in SCZ-AR patients compared to other subgroups of participants. Higher AL index was associated with more severe general psychopathology and depressive symptoms, lower scores of attention and semantic fluency, as well as worse social functioning in patients with psychosis. There was a significant negative correlation between the AL index and performance of attention in FHR-P individuals. There were no significant correlations between the AL index and cognition in HCs. Conclusion Our findings imply that elevated AL might already occur at preclinical stages of psychosis and tends to progress with illness duration. Elevated AL index might be associated with neurocognitive impairments.
neurosciences,endocrinology & metabolism,psychiatry
What problem does this paper attempt to address?